文献速递脊柱关节炎其他结缔组织病

髓源性抑制细胞与单核细胞作为银屑病临床表型及活动度的生物标志物

Myeloid-derived suppressor cells and monocytes are biomarkers of the clinical phenotype and activity of psoriatic disease.
PubMed 文献 · Rheumatology (Oxford) · 2026-01-01

横断面研究纳入47例银屑病患者和10例年龄性别匹配的健康对照,用流式细胞术检测外周血髓源性抑制细胞及单核细胞亚群,发现银屑病患者成熟粒细胞型髓源性抑制细胞降低、单核细胞型髓源性抑制细胞升高、非经典单核细胞扩增,且粒细胞型髓源性抑制细胞与皮肤活动度相关,非经典单核细胞与关节活动度相关。

要点

  • 银屑病患者成熟粒细胞型髓源性抑制细胞低于健康对照,单核细胞型髓源性抑制细胞升高。
  • 非经典单核细胞在银屑病患者中扩增,与银屑病关节炎活动度相关。
  • 粒细胞型髓源性抑制细胞与皮肤活动度相关,提示可作为活动度生物标志物。

核心结论

  • 在银屑病中,粒细胞型髓源性抑制细胞与皮肤疾病活动度相关,而非经典单核细胞与肌肉骨骼特征相关,提示二者是银屑病疾病活动度的潜在生物标志物。
  • 作者指出需要进一步的前瞻性研究探讨这些细胞亚群的功能,以确认其与银屑病活动状态的关系。

研究设计与样本

  • 横断面研究,纳入47例银屑病患者和10例年龄、性别匹配的健康对照。
  • 采用多参数流式细胞术检测外周血粒细胞型及单核细胞型髓源性抑制细胞、经典、中间型和非经典单核细胞。
  • 按临床特征、银屑病表型和治疗分组比较上述细胞群体,并用多变量逻辑回归和线性回归评估其预测银屑病面积和严重程度指数及银屑病关节炎疾病活动度的能力。

主要发现

  • 与健康对照相比,银屑病患者成熟粒细胞型髓源性抑制细胞降低(5.88% vs 60.97%),单核细胞型髓源性抑制细胞升高(0.62% vs 0.02%),精氨酸酶-1和程序性死亡配体1表达降低,非经典单核细胞扩增(12.2% vs 4.68%)。
  • 有皮肤特征的患者中可见成熟粒细胞型髓源性抑制细胞升高和精氨酸酶-1表达降低。
  • 粒细胞型髓源性抑制细胞与皮肤疾病活动度相关(银屑病面积和严重程度指数 β=5.05,P=0.05)。
  • 非经典单核细胞与活动性银屑病关节炎相关(银屑病关节炎疾病活动度 β=0.68,P=0.004)。

局限性

  • 作者指出需要进一步的前瞻性研究探讨这些细胞亚群的功能,以确认其与银屑病活动状态的关系。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To assess the relation between the proportion of myeloid-derived suppressor cells (MDSCs), monocyte subsets, and the clinical phenotypes and disease activity of psoriatic disease (PsD), including psoriasis (PsO) and PsA. METHODS: We carried out a cross-sectional study including 47 patients with PsD and 10 age- and sex-paired healthy controls. Using multiparametric flow cytometry, we evaluated the granulocytic (G) and monocytic (M) MDSCs, classical, intermediate and non-classical monocytes in peripheral blood. We compared these cell populations according to the clinical features, phenotype of PsD, and treatment groups. We evaluated their capability to predict disease activity measured by Psoriasis Area and Severity Index (PASI) and Disease Activity in Psoriatic Arthritis (DAPSA) by multivariate logistic and linear regressions. RESULTS: In comparison with healthy donors, PsD patients displayed lower mature G-MDSCs (5.88% vs 60.97%), increased M-MDSCs (0.62% vs 0.02%), decreased expression of arginase-1 and Programmed death-ligand 1 (PDL1), and expansion of non-classical monocytes (12.2% vs 4.68%). Increased mature G-MDSCs and decreased arginase-1 expression were seen in patients with cutaneous features. G-MDSCs were associated with cutaneous disease activity [PASI (β = 5.05, P = 0.05)], whilst non-classical monocytes were related to active PsA [DAPSA (β = 0.68, P = 0.004)], highlighting their potential as disease activity biomarkers. CONCLUSION: In PsD, G-MDSCs relate to cutaneous disease activity, whereas non-classical monocytes correlate with musculoskeletal features, highlighting their role as potential biomarkers of disease activity in PsD. Further prospective studies addressing the function of these cell subtypes would confirm their relationship with PsD activity status.

来源:Rheumatology (Oxford),查看原文。版权归原作者所有。

引用

  1. Balderas-Miranda JT, Torres-Ruiz J, Guaracha-Basañez GA, et al. Myeloid-derived suppressor cells and monocytes are biomarkers of the clinical phenotype and activity of psoriatic disease. Rheumatology (Oxford). 2026. PMID: 40891880. doi:10.1093/rheumatology/keaf465

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。